Bioactives and metabolites of Tetrastigma hemsleyanum root extract alleviate DSS-induced ulcerative colitis by targeting the SYK protein in the B cell receptor signaling pathway
Open Access
- 15 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 322, 117563
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Docking with AutoDock42019
- A review of the diagnosis, prevention, and treatment methods of inflammatory bowel diseaseJournal of Medicine and Life, 2019
- Molecular Docking: Challenges, Advances and its Use in Drug Discovery PerspectiveCurrent Drug Targets, 2019
- A next generation probiotic, Akkermansia muciniphilaCritical Reviews in Food Science and Nutrition, 2018
- TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent ModelsThe Journal of Pharmacology and Experimental Therapeutics, 2018
- A germline-limited piggyBac transposase gene is required for precise excision in Tetrahymena genome rearrangementNucleic Acids Research, 2017
- The Pharmacological Potential of RutinSaudi Pharmaceutical Journal, 2017
- cytoHubba: identifying hub objects and sub-networks from complex interactomeBMC Systems Biology, 2014
- Quantitative Metabolomic Profiling of Serum and Urine in DSS-Induced Ulcerative Colitis of Mice by 1H NMR SpectroscopyJournal of Proteome Research, 2010
- The SYK tyrosine kinase: a crucial player in diverse biological functionsNature Reviews Immunology, 2010